Procaps Group S.A. (PROCF)

OTCMKTS · Delayed Price · Currency is USD
1.450
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT
-43.36%
Market Cap 163.60M
Revenue (ttm) 414.10M
Net Income (ttm) 52.20M
Shares Out 112.82M
EPS (ttm) 0.52
PE Ratio 2.81
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 2,437
Open 1.450
Previous Close 1.450
Day's Range 1.450 - 1.450
52-Week Range 0.500 - 1.630
Beta -0.29
RSI 54.18
Earnings Date May 2, 2025

About Procaps Group

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers ... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 5,500
Stock Exchange OTCMKTS
Ticker Symbol PROCF
Full Company Profile

Financial Performance

Financial Statements

News

Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership

New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance

9 days ago - GlobeNewsWire

Nasdaq delists Colombia's Procaps Group due to financial shortfalls

Nasdaq recently announced the removal of the Procaps Group due to its failure to complete financial reporting standards on time, a significant decision that illustrates the difficulty that businesses ...

2 months ago - Invezz